E-LIB Suche - Ergebnisse für: Mordenti, Joyce

1

Minimization of CYP2D6 Polymorphic Differences and Improved..:

Chew, Marci L. ; Mordenti, Joyce ; Yeoh, Thean...
Pharmaceutical Research. 33 (2016) 8 - p. 1873-1880 , 2016

2

Clinical Pharmacokinetic Studies of Enzalutamide:

Gibbons, Jacqueline A. ; Ouatas, Taoufik ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 54 (2015) 10 - p. 1043-1055 , 2015

Link: https://doi.org/10.1007/..

3

Pharmacokinetic Drug Interaction Studies with Enzalutamide:

Gibbons, Jacqueline A. ; de Vries, Michiel ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 54 (2015) 10 - p. 1057-1069 , 2015

Link: https://doi.org/10.1007/..

4

In vitro assessment of cytochrome P450 inhibition: Strategi..:

Lin, Tong ; Pan, Kristine ; Mordenti, Joyce.
Journal of Pharmaceutical Sciences. 96 (2007) 9 - p. 2485-2493 , 2007

Link: https://doi.org/10.1002/..

5

Identification of metabolites of the tryptase inhibitor CRA..:

Yu, Walter ; Dener, Jeffrey M. ; Dickman, Daniel A....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 15 - p. 4053-4058 , 2006

Link: https://doi.org/10.1016/..

6

Small molecule inhibitors of plasma kallikrein:

Young, Wendy B. ; Rai, Roopa ; Shrader, William D....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 7 - p. 2034-2036 , 2006

Link: https://doi.org/10.1016/..

7

Factor VIIa inhibitors: Improved pharmacokinetic parameters:

Kolesnikov, Aleksandr ; Rai, Roopa ; Young, Wendy B....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 8 - p. 2243-2246 , 2006

Link: https://doi.org/10.1016/..

8

Factor VIIa inhibitors: A prodrug strategy to improve oral ..:

Riggs, Jennifer R. ; Kolesnikov, Aleksandr ; Hendrix, John...
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 8 - p. 2224-2228 , 2006

Link: https://doi.org/10.1016/..

9

Factor VIIa inhibitors: Chemical optimization, preclinical ..:

Young, Wendy B. ; Mordenti, Joyce ; Torkelson, Steven...
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 7 - p. 2037-2041 , 2006

Link: https://doi.org/10.1016/..

10

Efficacy and Concentration-Response of Murine Anti-VEGF Mon..:

Mordenti, Joyce ; Thomsen, Karen ; Licko, Vojtech...
Toxicologic Pathology. 27 (1999) 1 - p. 14-21 , 1999

Link: https://doi.org/10.1177/..

11

Comparisons of the Intraocular Tissue Distribution, Pharmac..:

Mordenti, Joyce ; Cuthbertson, R. Andrew ; Ferrara, Napoleone...
Toxicologic Pathology. 27 (1999) 5 - p. 536-544 , 1999

Link: https://doi.org/10.1177/..

12

Pharmacokinetics and Interspecies Scaling of Recombinant Hu..:

Mordenti, Joyce ; Osaka, Gary ; Garcia, Kit...
Toxicology and Applied Pharmacology. 136 (1996) 1 - p. 75-78 , 1996

Link: https://doi.org/10.1006/..

13

Pharmacokinetics, Tissue Distribution, and Expression Effic..:

Osaka, Gary ; Carey, Kendall ; Cuthbertson, Andrew...
Journal of Pharmaceutical Sciences. 85 (1996) 6 - p. 612-618 , 1996

Link: https://doi.org/10.1021/..

14

Expression of Exposure in Negative Carcinogenicity Studies:..:

Monro, Alastair ; Mordenti, Joyce
Toxicologic Pathology. 23 (1995) 2 - p. 187-198 , 1995

Link: https://doi.org/10.1177/..

15

Safety, Pharmacokinetics, and Antiviral Response of CD4-Imm..:

Collier, Ann C. ; Coombs, Robert W. ; Katzenstein, David...
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10 (1995) 2 - p. 150-156 , 1995

Link: https://doi.org/10.1097/..